Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- T3PAHIndependent statistical analysis of Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03528902).
- TACACIndependent statistical analysis of Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206518).
- TACEIndependent statistical analysis of Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00539253).
- TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve: Complete Statistical AnalysisIndependent statistical analysis of TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TACKLEIndependent statistical analysis of Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: primary endpoint results,…
- Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01680861).
- Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- TACTIndependent statistical analysis of A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TACTIC AFIndependent statistical analysis of Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TactiSenseIndependent statistical analysis of TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03354663).
- Taekwondo Training and Postmenopausal Women With Stage-2 Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Taekwondo Training and Postmenopausal Women With Stage-2 Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03544307).
- TAILOR-PCIIndependent statistical analysis of Tailored Antiplatelet Therapy Following PCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01742117).
- Tailored Approaches to Improve Medication Adherence: Complete Statistical AnalysisIndependent statistical analysis of Tailored Approaches to Improve Medication Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643473).
- Tailored Computerized Mobilization of the Cervical Spine Utilizing the Occiflex Device for the Treatment of Chronic Neck Pain: Complete Statistical AnalysisIndependent statistical analysis of Tailored Computerized Mobilization of the Cervical Spine Utilizing the Occiflex Device for the Treatment of Chronic Neck Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tailored Health Self-Management Interventions for Highly Distressed Family Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Tailored Health Self-Management Interventions for Highly Distressed Family Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03023332).
- Tailored-AFIndependent statistical analysis of Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04702451).
- Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Tailoring Treatment Targets for Early Autism Intervention in Africa: Complete Statistical AnalysisIndependent statistical analysis of Tailoring Treatment Targets for Early Autism Intervention in Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04068688).
- TailwindIndependent statistical analysis of Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection: primary endpoint results, effect…
- TAK-114 Single- and Multiple-Dose Phase 1 Study: Complete Statistical AnalysisIndependent statistical analysis of TAK-114 Single- and Multiple-Dose Phase 1 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02286518).
- TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI): Complete Statistical AnalysisIndependent statistical analysis of TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03477903).
- TAKE-ITIndependent statistical analysis of Intervention to Improve Adherence in Teen Kidney Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01356277).
- TALAPRO-2Independent statistical analysis of Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395197).
- Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval,…
- TALCIndependent statistical analysis of Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC):…
- TALENTIndependent statistical analysis of An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin: Complete Statistical AnalysisIndependent statistical analysis of Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00402025).
- Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TALONIndependent statistical analysis of Rapid Sternal Closure System (TALON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00638014).
- TAMBEIndependent statistical analysis of Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TAMEIndependent statistical analysis of Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TAMEIndependent statistical analysis of Therapy in Amyotrophic Lateral Sclerosis (TAME): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02118727).
- Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00710970).
- Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00295646).
- Tamoxifen/BTBIndependent statistical analysis of Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02903121).
- Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions: Complete Statistical AnalysisIndependent statistical analysis of Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01149733).
- tAN to Mitigate Withdrawal Behaviors in Neonates: Complete Statistical AnalysisIndependent statistical analysis of tAN to Mitigate Withdrawal Behaviors in Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04588519).
- TANDEMIndependent statistical analysis of Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis: primary endpoint results, effect estimate with…
- Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment: Complete Statistical AnalysisIndependent statistical analysis of Tandem Auto Transplantation in Myeloma Patients With
- Tandem VR: Synchronized Nature-Based Experiences in Virtual Reality for Hospice Patients and Their Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Tandem VR: Synchronized Nature-Based Experiences in Virtual Reality for Hospice Patients and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…